Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease

Gouilly, Dominique; Salabert, Anne-Sophie; Bertrand, Elsa; Goubeaud, Marie; Catala, Hélène; Germain, Johanne; Ainaoui, Nadéra; Rafiq, Marie; Benaiteau, Marie; Carlier, Jasmine; Nogueira, Leonor; Planton, Mélanie; Hitzel, Anne; Méligne, Déborah; Sarton, Benjamine; Silva, Stein; Lemesle, Béatrice; Payoux, Pierre; Thalamas, Claire; Péran, Patrice; Pariente, Jérémie

doi:10.3389/fneur.2023.1189278

Cited by 3 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, TSPO expression is not the only indicator of inflammatory activity, and it may be associated with the activation of other cell types, such as astrocytes. [ 25 , 33 ] Therefore, future studies need to include more biomarkers to be able to more fully reflect the neuroinflammatory state of dementia.…”

Section: Discussionmentioning

confidence: 99%

Neuroinflammation in dementia: A meta-analysis of PET imaging studies

Pan,

Hu,

Meng

et al. 2024

Medicine

View full text Add to dashboard Cite

Background: Dementia is a major public health challenge for aging societies worldwide. Neuroinflammation is thought to be a key factor in dementia development. The aim of this study was to comprehensively assess translocator protein (TSPO) expression by positron emission tomography (PET) imaging to reveal the characteristics of neuroinflammation in dementia. Methods: We used a meta-analysis to retrieve literature on TSPO expression in dementia using PET imaging technology, including but not limited to the quality of the study design, sample size, and the type of TSPO ligand used in the study. For the included studies, we extracted key data, including TSPO expression levels, clinical characteristics of the study participants, and specific information on brain regions. Meta-analysis was performed using R software to assess the relationship between TSPO expression and dementia. Results: After screening, 12 studies that met the criteria were included. The results of the meta-analysis showed that the expression level of TSPO was significantly elevated in patients with dementia, especially in the hippocampal region. The OR in the hippocampus was 1.50 with a 95% CI of 1.09 to 1.25, indicating a significant increase in the expression of TSPO in this region compared to controls. Elevated levels of inflammation in the prefrontal lobe and cingulate gyrus are associated with cognitive impairment in patients. This was despite an OR of 1.00 in the anterior cingulate gyrus, indicating that TSPO expression in this region did not correlate significantly with the findings. The overall heterogeneity test showed I² = 51%, indicating moderate heterogeneity. Conclusion: This study summarizes the existing literature on TSPO expression in specific regions of the brain in patients with dementia, and also provides some preliminary evidence on the possible association between neuroinflammation and dementia. However, the heterogeneity of results and limitations of the study suggest that we need to interpret these findings with caution. Future studies need to adopt a more rigorous and consistent methodological design to more accurately assess the role of neuroinflammation in dementia, thereby providing a more reliable evidence base for understanding pathological mechanisms and developing potential therapeutic strategies.

show abstract

Section: Discussionmentioning

confidence: 99%